The invention relates to a stimulation device for electrotherapy, in particular a defibrillator device and/or external pacemaker device, comprising at least two contact electrodes, which can be applied to the body of a patient at suitable stimulation positions and by means of which current pulses can be applied to the body of the patient, the first of the at least two contact electrodes acting as a charging electrode having positive polarity, and the second of the at least two contact electrodes acting as a discharging electrode having negative polarity with respect to an emitted current pulse, and with a current pulse generator, which is or can be connected to the contact electrodes by means of line connections. The invention further relates to a method for determining the polarity of contact electrodes applied to the body of a patient.

A wearable medical system configured to be worn by a person, comprising a support structure configured to be worn by the person, a monitoring device configured to monitor at least one physiological parameter of the person, wherein the at least one physiological parameter includes an electrocardiogram (ECG) reading of the person, an electrode coupled to the support structure, an energy storage device configured to store an electric charge for use in delivering a shock to the person through the electrode, and a biasing mechanism comprising at least one of an inflatable device, a hydraulic device, an electromagnetic device, and/or a screw gun device, the biasing mechanism configured to transition from the unbiased state to the biased state responsive to a value of the at least one physiological parameter reaching a threshold. The electrode is more movable with respect to the person's body in the unbiased state than the biased state.

A defibrillation device for administering an electrotherapy, such as a dual-sequential defibrillation (DSD) electrotherapy. The defibrillation device can include a defibrillation therapy module, a physiological parameter module and a control module. The defibrillation therapy module can output one or more energies and the physiological parameter module can receive one or more physiological parameters, including electrocardiogram (ECG) data. The control module can analyze the physiological parameters to determine an indication for the administration of an electrotherapy and can determine a DSD electrotherapy. The DSD electrotherapy can be based at least in part on the physiological parameters, the indication for the administration of an electrotherapy or a review of the ECG data.

A method for a wearable cardioverter defibrillator (WCD) system comprises sensing one or more patient parameters from different parts of a body of the patient by the one or more transducers, obtaining a plurality of physiological inputs from the sensed one or more patient parameters, detecting first aspects from each of at least some of the physiological inputs, generating an aggregated first aspect from at least two of the detected first aspects, determining an aggregate analysis score from the aggregated first aspect, and determining whether the aggregate analysis score meets an aggregate shock criterion. The electrical charge is discharged within six minutes from when it is determined that the aggregate shock criterion is met, otherwise the electrical charge is not discharged for at least 19 minutes from when it is determined that the aggregate shock criterion is not met.

A method for performing CPR with a mobile defibrillator (AED) unit can include detecting, via an application on a user device, a connection of a mobile AED unit to the user device; detecting, via the application, that pads have been attached to a subject, the pads comprising at least one accelerometer; recording, via the application, EKG measurements of the subject made by the pads; receiving accelerometer data from the at least one accelerometer; analyzing the accelerometer data to determine a breathing pattern of the subject; and based on the determined breathing pattern, initiating a CPR protocol.

A wearable therapeutic device includes an external defibrillator configured to monitor electrical heart activity of a patient and a garment housing a first therapy electrode and a second therapy electrode. The first and second therapy electrodes are electrically coupled to the defibrillator. The garment releasably receives a plurality of replaceable receptacles configured to store a conductive gel in locations proximate to the therapy electrodes. A plurality of gas cartridges each disposed on one of the plurality of replaceable receptacles are configured to control a release of the stored conductive gel of the associated one of the plurality of replaceable receptacles by igniting. A plurality of conductive gel firing circuits each associated with and separate from each of the plurality of replaceable receptacles are configured to be operatively coupled to the gas cartridge to control the release of the stored conductive gel upon information being communicated from the external defibrillator.

In some embodiments, a wearable cardioverter defibrillator (“WCD”) system comprises a support structure configured to be worn by a patient, a power source, an energy storage module configured to be coupled to the support structure, to be charged from the power source and to store an electrical charge, a discharge circuit coupled to the energy storage module, the discharge circuit controllable to discharge the electrical charge so as to cause a shock to be delivered to the patient, a measurement circuit configured to render a physiological input from a patient physiological signal, a user interface configured to output one or more human-perceptible indications, and a processor. The processor can be configured to detect a cardiac arrhythmia of the patient from the physiological input, determine whether a type of the cardiac arrhythmia is at least one of a first type (“CA1”) and a second type (“CA2”), if the type is CA1, cause a first human-perceptible indication to be output, else if the type is CA2, cause a second human-perceptible indication to be output, the second human-perceptible indication being different from the first human-perceptible indication, and then control the discharge circuit to deliver a shock responsive to the cardiac arrhythmia.

In one embodiment, a wearable cardioverter defibrillator (WCD) is described. The WCD includes a support structure that may be worn by a patient. A processor is coupled to the support structure. The wearable cardioverter defibrillator also includes a discharge circuit configured to discharge a stored electrical charge through a body of the patient, the discharge circuit in communication with the processor. The processor may be configured to detect an event occurring at the WCD and determine a severity of the event occurring at the WCD. The processor may activate a multi-sensory alarm based at least in part on the determined event severity.

The disclosure describes a medical electrical lead including bonding strip to bond an elongate electrode coil to an elongate lead body to reduce damage to the medical electrical lead during manipulation of the medical electrical lead. The elongate lead body extends from a proximal end to a distal end and includes a proximal portion and a distal portion. The elongate electrode coil surrounds at least part of the distal portion of the elongate lead body. The bonding strip extends axially along the elongate electrode coil and extends only partially around the circumference of the elongate electrode coil for at least part of the length of the bonding strip, where at least a portion of the bonding strip is bonded to the elongate lead body to fix a portion of the elongate electrode coil to the elongate lead body.

A subcutaneous implantable medical device and method (SIMD) provided. A pulse generator (PG) is configured to be positioned subcutaneously within a lateral region of a chest of a patient. The PG has a housing that includes a PG electrode. The PG has an electronics module. An elongated lead is electrically coupled to the pulse generator. The elongated lead includes a first electrode that is configured to be positioned along a first parasternal region proximate a sternum of the patient and a second electrode that is configured to be positioned at an anterior region of the patient. The first and second electrodes are coupled to be electrically common with one another. The electronics module is configured to provide electrical shocks for antiarrhythmic therapy along at least one shocking vector between the PG electrode and the first and second electrodes.